(PRWEB UK) 22 October 2014
Antibodies are gaining a dominant role in the treatment of many life-threatening situations like cancer or autoimmune diseases due to their excellent safety/efficacy profile compared to other, conventional drugs. This masterclass will provide an introduction to therapeutic antibodies, pitfalls to be avoided in their development and strategies for their state-of-the-art design. In addition to the description of the current status new emerging developments and trends will be highlighted.
Key Benefits of attending:
- Understand the contextual backdrop to the therapeutic antibody industry
- Discuss the latest generation of antibodies and their features
- Learn from the advice offered and apply to your own projects
Who should attend:
Persons working for Biotech, Big Pharma, CMOs, Analytical Service Providers: Scientific staff in the fields of Discovery, Protein Engineering, Protein Analytics, Bioanalytics, Assay Development (Group+Lab Heads, Scientists of all levels), Ab-Project leader, Regulatory Managers, QA/QC.
For more information on the workshop or to register, please go to http://www.smi-online.co.uk/2014therapeutic-antibodies8.asp
Alternatively, contact Fateja Begum on tel: +44 (0) 20 7827 6184 or email: fbegum(at)smi-online(dot)co(dot)uk